HALOG Drug Patent Profile
✉ Email this page to a colleague
When do Halog patents expire, and when can generic versions of Halog launch?
Halog is a drug marketed by Sun Pharm Inds Inc, Westwood Squibb, and Bristol Myers Squibb. and is included in six NDAs.
The generic ingredient in HALOG is halcinonide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the halcinonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Halog
A generic version of HALOG was approved as halcinonide by MYLAN on August 12th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HALOG?
- What are the global sales for HALOG?
- What is Average Wholesale Price for HALOG?
Summary for HALOG
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Patent Applications: | 4,425 |
Drug Prices: | Drug price information for HALOG |
What excipients (inactive ingredients) are in HALOG? | HALOG excipients list |
DailyMed Link: | HALOG at DailyMed |
Pharmacology for HALOG
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for HALOG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | HALOG | halcinonide | CREAM;TOPICAL | 017556-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sun Pharm Inds Inc | HALOG | halcinonide | OINTMENT;TOPICAL | 017824-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Westwood Squibb | HALOG | halcinonide | CREAM;TOPICAL | 017818-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |